# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
ShareCap calls on the Board to initiate a strategic alternatives process that, among the alternatives, reconsiders Future Pak...
"Supreme Court denies review of Vanda Pharmaceuticals' patent revival attempt for Hetlioz sleep-disorder medication. Le...
https://finance.yahoo.com/news/1-u-supreme-court-rejects-153720025.htmlThe U.S. Supreme Court on Monday declined to hear a bid ...
https://ml.globenewswire.com/Resource/Download/9ee5bd01-bdbc-43f7-af2d-e4c34004b336Dear Members of the Board: A fund managed by...
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling more than 100 points on Wednesday. The D...
Shares of The Travelers Companies, Inc. (NYSE: TRV) fell sharply during Wednesday’s session following first-quarter earnings.
Vanda Pharmaceuticals rebuffs unsolicited proposals from Future Pak LLC, citing undervaluation. Offers up to $7.75 per share. B...
Vanda Pharmaceuticals Inc. ("Vanda" or the "Company") (NASDAQ:VNDA) today announced that its Board of Directors...